Samante, Reniel Jay A.
HRN: 22-95-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/24/2023
05/01/2023
IV
1g
Q6
PCAP
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes